Conference
Meta-analysis of the impact of single agent daily prednisone on outcomes and toxicities in metastatic castration-resistant prostate cancer (mCRPC).
Authors
Ghatalia P; Pond GR; Templeton AJ; Sonpavde G
Volume
33
Pagination
pp. e16095-e16095
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2015
DOI
10.1200/jco.2015.33.15_suppl.e16095
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X